In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins
Abstract
The pandemic caused by SARS-CoV-2 is currently representing a major health and economic threat to humanity. So far, no specific treatment to this viral infection has been developed and the emergency still requires an efficient intervention. In this work, we used virtual screening to facilitate drug repurposing against SARS-CoV-2, targeting viral main proteinase and spike protein with 3000 existing drugs. We used a protocol based on a docking...
Paper Details
Title
In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins
Published Date
Sep 7, 2020
Journal
Volume
19
Issue
11
Pages
4637 - 4648
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History